The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Inhibition of Stat3‐mediated astrogliosis ameliorates pathology in an Alzheimer's disease model
Open accessAbstract
Reactive astrogliosis is a hallmark of Alzheimer's disease (AD), but its role for disease initiation and progression has remained incompletely understood. We here show that the transcription factor Stat3 (signal transducer and activator of transcription 3), a canonical inducer of astrogliosis, is activated in an AD mouse model and human AD. Therefore, using a conditional knockout approach, we deleted Stat3 specifically in astrocytes in the APP/PS1 model of AD. We found that Stat3‐deficient APP/PS1 mice show decreased β‐amyloid levels and plaque burden. Plaque‐close microglia displayed a more complex morphology, internalized more β‐amyloid, and upregulated amyloid clearance pathways in Stat3‐deficient mice. Moreover, astrocyte‐specific Stat3‐deficient APP/PS1 mice showed decreased pro‐inflammatory cytokine activation and lower dystrophic neurite burden, and were largely protected from cerebral network imbalance. Finally, Stat3 deletion in astrocytes also strongly ameliorated spatial learning and memory decline in APP/PS1 mice. Importantly, these protective effects on network dysfunction and cognition were recapitulated in APP/PS1 mice systemically treated with a preclinical Stat3 inhibitor drug. In summary, our data implicate Stat3‐mediated astrogliosis as an important therapeutic target in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, the manipulation of reactive astrocytes has resulted in improved outcomes38,42,43, worse35 outcomes, and no change44 in mouse models of AD and MS40,45,46.”
From Reactive astrocyte nomenclature, definitions, and future directions (2021) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“On the other hand, blocking astrocyte reactivity has demonstrated positive effects on pathology (Ceyzeriat et al., 2018; Reichenbach et al., 2019).”
From Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease (2024) · cites this paper as Reichenbach et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Self-citationMorris water maze: procedures for assessing spatial and related forms of learning and memory
Vorhees, C. V., & Williams, M. T. (2006) · Nature Protocols · doi:10.1038/nprot.2006.116 · Cited by 4,629
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Genomic analysis of reactive astrogliosis
Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., & Barres, B. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6221-11.2012 · Cited by 2,404
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Reactive Gliosis and the Multicellular Response to CNS Damage and Disease
Burda, J. E., & Sofroniew, M. V. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.034 · Cited by 1,500
The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease
Barres, B. A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.013 · Cited by 1,352
Mechanisms and consequences of Jak–STAT signaling in the immune system
Villarino, A. V., Kanno, Y., & O'Shea, J. J. (2017) · Nature Immunology · doi:10.1038/ni.3691 · Cited by 1,221
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 351
Kushwaha, R., Molesworth, K., Makarava, N., & Baskakov, I. V. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02028-6 · Cited by 7
Wnt5a/Ror2 promotes Nrf2‐mediated tissue protective function of astrocytes after brain injury
Endo, M., Tanaka, Y., Fukuoka, M., Suzuki, H., & Minami, Y. (2023) · Glia · doi:10.1002/glia.24483 · Cited by 5
Sawant, N., Watanabe, A., Ueda, H., Okano, H., & Morita, M. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114700 · Cited by 5
The identification of a Distinct Astrocyte Subtype that Diminishes in Alzheimer’s Disease
Wei, H., Withrow, J. S., Rakshit, J., Amin, F. U., Nahm, J., Mowry, F. E., Mao, Z., Bhattacharjee, M. B., Zhu, J., Yang, Y., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0205-1 · Cited by 7
STATs, promising targets for the treatment of autoimmune and inflammatory diseases
He, X., Liu, P., Luo, Y., Fu, X.-Y., & Yang, T. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116783 · Cited by 5
Zhao, X., Wang, X., Xu, Z., Chang, X., & Tian, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167545 · Cited by 5
Stat3 mediates Fyn kinase-driven dopaminergic neurodegeneration and microglia activation
Siddiqui, S., Liu, F., Kanthasamy, A. G., & McGrail, M. A. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.052011 · Cited by 5
Astrocytes phenomics as new druggable targets in healthy aging and Alzheimer’s disease progression
Lana, D., Ugolini, F., Iovino, L., Attorre, S., & Giovannini, M. G. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1512985 · Cited by 6
Gu, S., & Ran, C. (2025) · iRadiology · doi:10.1002/ird3.70002 · Cited by 5
de Munter, J., Chaprov, K., Lang, E., Sitdikova, K., Wolters, E. C., Svirin, E. P., Kassenova, A., Tsoy, A., Kramer, B. W. W., Askarova, S., et al. (2025) · Cells · doi:10.3390/cells14151168 · Cited by 6
Sun, Y., Wen, X., Li, Z., Xu, L., & Xia, M. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001958 · Cited by 5
Single Nuclei Transcriptome Reveals Perturbed Brain Vascular Molecules in Alzheimer’s DiseasePreprint
İş, Ö., Wang, X., Patel, T., Quicksall, Z., Heckman, M. G., White, L. J., Lewis‐Tuffin, L. J., Deniz, K., Tutor‐New, F. Q., Carnwath, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.28.474255 · Cited by 5
Luo, Y., Zang, N., Tang, Y., Chen, H., Liu, H., Wang, L., & Xu, P. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08812-2 · Cited by 4
Aberrant activation of the mTOR signaling pathway in Rasmussen encephalitis
Qiao, J., Tang, C., Xie, M., Gong, M., Fu, C., Cheng, Z., Chen, Z., Mei, A., Bo, Y., Zhao, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-89426-x · Cited by 4
Ahmed, A. T., Oghenemaro, E. F., Hjazi, A., Jain, V. D., Ahmad, I., Roopashree, R., Soothwal, P. K., Goswami, M., Zwamel, A. H., & Kdhim, K. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01816-0 · Cited by 4
Cheng, H., Chen, N., Tang, Y.-C., Shih, P., Chen, W.-F., Chiu, Y.-J., Sung, C., & Wen, Z. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00763 · Cited by 6
Harit, K., Yi, W., Jeron, A., Schmidt, J., Beckervordersandforth, R., Wyler, E., Manukyan, A., Deckert, M., Radbruch, H., Conrad, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65093-4 · Cited by 5
Correale, J. D. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70414 · Cited by 4
Cao, Y., Lin, X., Gao, D., Yang, J., Miao, H., & Li, T. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114095 · Cited by 4
Liu, S., Zhang, Z., Li, L., Yao, L., Ma, Z. S., & Li, J. (2022) · The FASEB Journal · doi:10.1096/fj.202201396r · Cited by 4
Kim, H., Leng, K., Park, J., Sorets, A. G., Kim, S., Shostak, A., Sturgeon, S. M., Neal, E. H., McMahon, D. G., Schrag, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.21.481336 · Cited by 4
Siciliano, B., Henkel, N., Ryan, W. G., Imami, A. S., Vergis, J. M., Xu, C., Arvay, T. O., Sahay, S., Pulvender, P., Hamoud, A.-R. A., et al. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101044 · Cited by 4
Crebanine attenuates copper neurotoxicity via PACS-2 upregulation and TXNIP/TRPV1 axis suppression
Mohammed, O. A., Hashish, A. A., Doghish, A. S., Sohail, S. K., Rizvi, S. F., Saleh, L. A., Eleragi, A. M. S., Rahman, M.-N. A.-E., Aboregela, A. M., Attia, M. A., et al. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103448 · Cited by 3
Saliu, I. O., & Zhao, G. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01790 · Cited by 3
Yang, G., & Shi, J. (2022) · Open Medicine · doi:10.1515/med-2022-0565 · Cited by 3
Deciphering the molecular mechanism of REST regulation through DEGs and TFs in Alzheimer's disease
Nassar, A., Nampoothiri, M., Gurram, P. C., Satarker, S., Upadhya, D., Shamabhat, G., & Mahammad, F. S. (2023) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.152245 · Cited by 3
Ye, H., Wan, Y., Wang, X., Wang, S., Zhao, X., Wang, X., Yu, T., Yan, C., Tian, X., Chen, Z., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70038 · Cited by 6
Wei, Z., Liu, C., Chen, J., Yao, Y., & Qin, D. (2025) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70015 · Cited by 3
Genome-wide discovery of hidden genes mediating known drug-disease association using KDDANet
Yu, H., Lu, L., Chen, M., Li, C., & Zhang, J. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00216-6 · Cited by 3
Thumu, S. C. R., Jain, M., Soman, S., Das, S., Verma, V., Nandi, A., Gutmann, D. H., Balaji, J., Nair, D. K., Clement, J. P., et al. (2024) · eLife · doi:10.7554/elife.95577 · Cited by 2
BMAL1 in Astrocytes: A Protective Role in Alzheimer’s and Parkinson’s Disease
Brash-Arias, D., García, L. I., Aranda-Abreu, G. E., Toledo‐Cárdenas, M. R., Pérez-Estudillo, C. A., & Chi-Castañeda, D. (2025) · Neuroglia · doi:10.3390/neuroglia6010001 · Cited by 2
Bellapianta, A., Qi, J., Giugliano, M., Ouaidat, S., Rawas, R. E., Bolz, M., & Salti, A. (2025) · Biomedicines · doi:10.3390/biomedicines14010045 · Cited by 2
Computational Multi-target Drug Design
Guruprasad, L., Saxena, S., Banerjee, A., & Boggarapu, G. (2025) · Springer handbooks · doi:10.1007/978-3-031-81728-1_28 · Cited by 2
REV-ERB-alpha and -beta coordinately regulate astrocyte reactivity and proteostatic function
Nadarajah, C. J., Li, M. Y., Quillin, E. I., Boyer, K., Dimitry, J. M., Chen, Y., King, M. W., Saliu, I. O., Lee, J., Sheehan, P. W., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2511093123 · Cited by 2
Poulot-Becq-Giraudon, Y., Guillemaud, O., Degl’Innocenti, E., Letenneur, V., Bascarane, K., Barbay, T., Clausen, M. M., Derbois, C., Guillermier, M., Juricek, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71826-w · Cited by 2
Mangoni, A. A., Hulin, J.-A., & Tommasi, S. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100147 · Cited by 2
Zhai, Y., Morihara, R., Feng, T., Hu, X., Fukui, Y., Bian, Z., Bian, Y., Yu, H., Sun, H., Takemoto, M., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148790 · Cited by 2
Astrocytic centrin‐2 expression in entorhinal cortex correlates with Alzheimer's disease severity
Degl’Innocenti, E., Poloni, T. E., Medici, V., Olimpico, F., Finamore, F., Profka, X., Bascarane, K., Morrone, C., Pastore, A., Escartin, C., et al. (2024) · Glia · doi:10.1002/glia.24603 · Cited by 2
Mei, J., Wang, S., Zhao, Y., Xu, T., Luo, Y., & Xiong, L. (2024) · Ibrain · doi:10.1002/ibra.12179 · Cited by 2
Yao, K., Mou, Q., Jiang, Z., & Zhao, Y. (2024) · Brain‐X · doi:10.1002/brx2.70005 · Cited by 2
Yuan, Q., Li, X., Chen, X., Xiao, J., & Zhang, J. (2025) · Oncology Reports · doi:10.3892/or.2025.8899 · Cited by 2
Dong, F., Shao, L., Gong, R., Shen, L., & Wang, L. (2025) · Molecular & Cellular Toxicology · doi:10.1007/s13273-025-00544-z · Cited by 2
Yu, X., Zhou, J., Wang, S., Lü, Y., Gu, Y., & Wang, X. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05266-w · Cited by 2
Astrocytic Activation Completely Corrects Memory Performance in an Alzheimer’s Disease ModelPreprint
Kreisel, T., Weinstein, Y., Groysman, M., Doron, A., Refaeli, R., London, M., & Goshen, I. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.29.679133 · Cited by 2
PINK1/Parkin-dependent mitophagy mediates astrocytic inflammatory responses to mitochondrial damagePreprint
Riley, J. F., Robbins, C. V., & Holzbaur, E. L. F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.11.724378 · Cited by 2
Zhu, X., Diep, Y. N., Tran, V. T. A., Kang, Y. J., Lee, L. P., & Cho, H. (2025) · BioChip Journal · doi:10.1007/s13206-025-00228-9 · Cited by 1
A protective role of SRC-1 against aging associated cognitive decline
Liu, H., Yang, Y., Bean, J. C., He, Y., Liu, H., Rambabu, M., Chen, L., Zhang, N., Yu, M., Tu, L., et al. (2025) · Aging · doi:10.18632/aging.206311 · Cited by 1
Zhou, C., & Peng, Y. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s523834 · Cited by 1
Zhang, Y., Hou, S., Li, J., Wang, W., Jia, S., Wang, X., Xia, Y., & Wang, Y. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70019 · Cited by 1
Li, R., Zhang, J., Wang, Q., Fan, J.-Q., & Lin, B. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01618-7 · Cited by 1
Targeting STAT3 in Alzheimer's disease: Potential mechanisms and therapeutic implications
Chen, P., Wang, R., Zhou, T., Sun, Y. N., Kirchhoff, F., Miao, Z., & Zhuang, C. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118785 · Cited by 1
Jiang, D., Yin, Z., Wu, X., Wang, X., Liang, B., Wei, X., & Yan, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05827-7 · Cited by 1
Chen, J., Lu, D., Chen, H., Xiao, C., Cheng, S., Lu, Q., Huang, M., Yang, C., Luo, J., Xu, J., et al. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116219 · Cited by 1
Ye, J., Deng, Y., Zhang, B., Li, C., Guo, X., Yue, R., Wan, H., Hao, Y., & Xiao, S. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02121-5 · Cited by 1
Innate immune signaling and functions in astrocytes
Guo, A. X., Fisher, T. M., Comandante-Lou, N., Jager, P. L. D., & Liddelow, S. A. (2026) · Nature Immunology · doi:10.1038/s41590-026-02561-z · Cited by 5
Yang, H., Su, B.-W., Bao, Y.-N., Wang, W.-H., Lao, J.-Y., Ji, H.-Y., Han, S., Cui, X.-H., Ren, H.-W., & Luan, Z.-L. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1880374 · Cited by 1
Is amyloid beta peptide a driver of inflammaging?
Kechko, O. I., Moskalev, A. A., Franceschi, C., Mitkevich, V. A., & Makarov, A. А. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103280 · Cited by 1
Effect of a high-fat diet and leptin on STAT3 phosphorylation in hippocampal astrocytes
Naranjo, V., Merino, B., Olmo, N. D., Frago, L. M., Chowen, J. A., Ruiz‐Gayo, M., & González, V. C. (2022) · Neuroreport · doi:10.1097/wnr.0000000000001855 · Cited by 1
Risen, S. J., Wahl, D., LaRocca, T. J., & Moreno, J. A. (2025) · Neuroglia · doi:10.3390/neuroglia6020022 · Cited by 1
Exploring Biomarkers Related to Autophagy in Alzheimer's Disease Based on Pathway Crosstalk AnalysisPreprint
Qian, F., Kong, W., & Wang, S. (2021) · Research Square · doi:10.21203/rs.3.rs-784797/v1 · Cited by 1
Edaravone promotes A1/A2 polarization of astrocytes through JAK2 / STAT3 pathwayPreprint
Liu, T.-T., Duan, Z., Jia, Q., Chen, H., Jia, W., Zheng, L., Xu, D.-Y., Yang, Y., Yuan, Y., Yang, L., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3072656/v1 · Cited by 1
Ye, H., Wan, Y., Wang, X., Wang, S., Zhao, X., Wang, X., Yu, T., Yan, C., Chen, Z., & Liu, X. (2024) · Research Square · doi:10.21203/rs.3.rs-3878760/v1 · Cited by 1
Genome-wide discovery of hidden genes mediating known drug-disease association using KDDANetPreprint
Yu, H., Lu, L., Chen, M., Li, C., & Zhang, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/749762
A novel equilibrative nucleoside transporter 1 inhibitor alleviates Tau-mediated neurodegenerationPreprint
Chang, C., Chang, Y., Chuang, P., Nguyen, T. N. A., Chou, F.-Y., Cheng, S., Chen, H., Jin, L., Carvalho, K., Huin, V., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.25.334201
Hu, Y., Zhang, X., Zhang, J., Li, H., Xia, X., Qiu, C., Liao, Y., Chen, H., Song, Z., & Zhou, W. P. (2020) · doi:10.21203/rs.2.23488/v1
Wang, J., Liu, B., Xu, Y., Wang, C.-Y., Yang, M.-Z., Song, M., Liu, J., You, J., Sun, F., Wang, W.-T., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-126764/v1
Liu, S., Zhang, Z., Li, L., Yao, L., Ma, Z. S., & Li, J. (2021) · Research Square · doi:10.21203/rs.3.rs-327896/v1
Zhang, Z., Li, H., Hui, S., Yi, M., Chen, X., Huang, J., Peng, W., & Yang, J. (2021) · Research Square · doi:10.21203/rs.3.rs-590600/v1
p38α-MAPK-deficient myeloid cells ameliorate symptoms and pathology of APP-transgenic AD micePreprint
Luo, Q., Schnöder, L., Hao, W., Litzenburger, K., Decker, Y., Tomic, I., Menger, M. D., Fassbender, K. C., & Liu, Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.18.464870
Serrano, S. (2006) · Cuadernos hispanoamericanos
Sims, S. G. (2021) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.10189
Liu, S., Zhang, Z., Li, L., Yao, L., Ma, Z. S., & Li, J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.11.426157
Neural Stem Cell-Derived Exosomes Protect Spinal Cord Injury by the Transfer of miR-31-5pPreprint
Jiang, D., Luo, Y., Wu, X., Huang, C., Liu, Y., Yin, Z., Li, J., Dawei, Y., Gu, Q., Zhang, Q., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1169988/v1
Johnson, T. S., Xiang, S., Dong, T., Huang, Z., Cheng, M., Wang, T., Yang, K., Ni, D., Huang, K., & Zhang, J. (2020) · Research Square · doi:10.21203/rs.3.rs-26385/v2
Johnson, T. S., Xiang, S., Dong, T., Huang, Z., Cheng, M., Wang, T., Yang, K., Ni, D., Huang, K., & Zhang, J. (2020) · doi:10.21203/rs.3.rs-92026/v1
Kynurenic acid promotes A1 to A2 astrocyte conversion against HIV-associated neurocognitive disorderPreprint
Lun, J., Li, Y., Gao, X., Gong, Z., Chen, X., Zou, J., Zhou, C., Huang, Y., Zhou, B., Huang, P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.11.499523
Neural stem cell-derived exosomes protect spinal cord injury by the transfer of miR-31-5pPreprint
Jiang, D., Luo, Y., Wu, X., Huang, C., Zhang, Q., Jiang, C., Yao, Q., Jiang, F., & Tang, P. (2022) · Research Square · doi:10.21203/rs.3.rs-1169988/v2
Juxtacrine DLL4-NOTCH1 signaling between astrocytes drives neuroinflammation via the IL-6-STAT3 axisPreprint
Mora, P., Laisné, M., Bourguignon, C., Rouault, P., Gadeau, A., Renault, M., Horng, S. H., Couffinhal, T., & Chapouly, C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.04.560826
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151181
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151178
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151166
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151172
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151169
Luo, L., Pan, Y., Chen, F., & Zhang, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4225413/v1
wang, H., Chen, X., Chen, M., Han, L., zhou, X., Liu, Z., Tan, L., Chen, W., & Ji, Z. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5117851
TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s diseasePreprint
Ceyzériat, K., Badina, A. M., Abjean, L., Meyer, L., Bouteldja, F., Bałkota, M., Amossé, Q., Prudhomme, O., Middleton, R. J., Liu, G.-J., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7008246/v1
ZEB2: a multifunctional regulator of neural injury repair
Nie, S., Fang, L., Wang, B., Chen, R., Wei, T., Zhang, Y., Ji, H., & Wu, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115266
Reactive Microglia and Astrocytes as Therapeutic Targets in Prion Diseases
Makarava, N., Kushwaha, R., & Baskakov, I. V. (2025) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-97055-9_8 · Cited by 1
Neuronal PARIS-STAT3 axis drives tau pathology and glial activation in Alzheimer’s diseasePreprint
Song, J.-Y., Akkentli, F., Jo, H., Park, J., Ha, S., Ochoa, J., Troncoso, J. C., Kang, S.-U., Dawson, V. L., & Dawson, T. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.06.692741
Zhang, R., Mu, S. M., Zhang, S., Qin, X., Du, G., & Zhou, Y. (2025) · Plant Foods for Human Nutrition · doi:10.1007/s11130-025-01455-z
Hwang, Y., Kim, H., & Shin, E.-J. (2022) · Figshare · doi:10.6084/m9.figshare.20056747
Wang, T., Sobue, A., Watanabe, S., Komine, O., Saido, T. C., Saito, T., & Yamanaka, K. (2024) · Figshare · doi:10.6084/m9.figshare.25264361
Lo, T. Y., Chan, A. S. L., Cheung, S. T., Yung, L. Y., Leung, M. M. H., & Wong, Y. H. (2024) · Figshare · doi:10.6084/m9.figshare.26610666
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151190
Eltom, K., Mothes, T., Libard, S., Ingelsson, M., & Erlandsson, A. (2024) · Figshare · doi:10.6084/m9.figshare.26685735
Li, L., Li, Y., He, B., Li, H., Ji, H., Wang, Y., Zhu, Z., Hu, Y., Zhou, Y., Yang, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16632875
Wu, C., Yang, L., Feng, S., Zhu, L., Yang, L., Liu, T. C., & Duan, R. (2022) · Figshare · doi:10.6084/m9.figshare.21259535
Eltom, K., Mothes, T., Libard, S., Ingelsson, M., & Erlandsson, A. (2024) · Figshare · doi:10.6084/m9.figshare.26685723
Eltom, K., Mothes, T., Libard, S., Ingelsson, M., & Erlandsson, A. (2024) · Figshare · doi:10.6084/m9.figshare.26685714
Eltom, K., Mothes, T., Libard, S., Ingelsson, M., & Erlandsson, A. (2024) · Figshare · doi:10.6084/m9.figshare.26685744
Metadata
- Authors
- Reichenbach, N., Delekate, A., Plescher, M., Schmitt, F., Krauss, S., Blank, N., Halle, A., & Petzold, G. C.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- University Hospital Bonn (DE)
- Corresponding author
- Petzold, Gabor C
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2019-01-07
- Volume
- 11
- Issue
- 2
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC6365929
- OpenAlex
- W2907017802
- Cited by
- 343
- References
- 42
- Citations by year
- 2026: 36 · 2025: 50 · 2024: 63 · 2023: 47 · 2022: 54 · 2021: 49 · 2020: 34 · 2019: 9
- FWCI
- 25.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DZNE Pub (submittedVersion, other-oa)
- Funders
- European Union (EU) Joint Program, Neurodegenerative Disease Research JPND (643417/DACAPO‐AD)
- Alzheimer Forschung Initiative
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Deutsche Forschungsgemeinschaft (EXC 1023)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- STAT3, astrocyte activation, Alzheimer's disease, APP/PS1 mice, amyloid-beta, amyloid plaques, microglia, amyloid clearance, neuroinflammation, inflammatory cytokines, dystrophic neurites, spatial learning and memory, STAT3 inhibitor, therapeutic target
- MeSH terms
- Alzheimer Disease, Animals, Astrocytes, Disease Models, Animal, Humans, Mice, Knockout, Cell Proliferation, STAT3 Transcription Factor, Mice, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review